Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal (posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy (for average-risk medulloblastoma
Version 2 2024-06-12, 14:13
Version 1 2015-03-17, 12:02
conference contribution
posted on 2024-06-12, 14:13 authored by TE Merchant, LE Kun, MJ Krasin, D Wallace, MM Chintagumpala, SY Woo, DM Ashley, M Sexton, SJ Kellie, V Ahern, A GajjarMulti-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal (posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy (for average-risk medulloblastoma
History
Volume
70Pagination
782-787Location
Salt Lake City, UTStart date
2003-10-19End date
2003-10-23ISSN
0360-3016Language
EnglishPublication classification
EN.1 Other conference paperTitle of proceedings
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSEvent
45th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-OncologyIssue
3Publisher
ELSEVIER SCIENCE INCUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineOncologyRadiology, Nuclear Medicine & Medical Imagingradiotherapyconformal radiotherapychemotherapypediatricscentral nervous system neoplasmNEWLY-DIAGNOSED MEDULLOBLASTOMACHILDRENS CANCER GROUPSTEM-CELL RESCUETUMOR BED BOOSTRADIATION-THERAPYCHILDHOOD MEDULLOBLASTOMAADJUVANT CHEMOTHERAPYPOSTERIOR-FOSSAINTERNATIONAL-SOCIETYPEDIATRIC-PATIENTS
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC